Prestige Consumer Healthcare INC Form 4 insider transactions

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, disposed of 457 shares of common stock to satisfy tax obligations.

Christine Sacco, CFO & COO of Prestige Consumer Healthcare, files an amendment to a previous Form 4 to correct an error in the reported number of shares held.

Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare, sold 354 shares of common stock to cover tax obligations arising from equity compensation.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, sold 315 shares of common stock on May 7, 2025, to cover tax obligations.

Christine Sacco, CFO & COO of Prestige Consumer Healthcare Inc., reports acquisition and disposal of common stock and restricted stock units.

William P'Pool, SVP, General Counsel & Corp Secretary of Prestige Consumer Healthcare, reports acquisition and disposal of company stock, including restricted stock units.

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, reports acquisition of restricted stock units.

Ronald M. Lombardi, CEO of Prestige Consumer Healthcare, acquired 12,352 shares of common stock through the vesting of restricted stock units.

Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc., reports the acquisition of 1,837 restricted stock units.

William P'Pool, SVP, General Counsel & Corp Secretary of Prestige Consumer Healthcare, reports transactions involving company stock, including acquisitions and disposals related to performance stock units.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, reports acquisition and disposal of company stock related to performance stock units.

CEO Ronald M. Lombardi reports acquisition and disposal of Prestige Consumer Healthcare Inc. stock related to performance stock units.

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, reports the acquisition and disposal of company stock related to performance stock units.

Christine Sacco, CFO & COO of Prestige Consumer Healthcare Inc., reports acquisition and disposal of company stock related to performance stock units.

Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare, reports stock transactions including the vesting and settlement of performance stock units.

Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare Inc., reports selling 1,678 shares of common stock at $90 per share on March 10, 2025.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, exercised stock options and sold shares on March 3, 2025.

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, exercised stock options and sold shares on February 11, 2025.

Christine Sacco, CFO & COO of Prestige Consumer Healthcare Inc., reports the acquisition of restricted stock units.

William P'Pool, a senior executive at Prestige Consumer Healthcare, reported a transaction involving the gifting of company stock.

Prestige Consumer Healthcare's CEO, Ronald M. Lombardi, exercised stock options and sold shares on November 19, 2024, according to a recent SEC filing.

Prestige Consumer Healthcare CEO Ronald M. Lombardi exercised stock options and sold shares on November 18, 2024.

William P'Pool, SVP, General Counsel & Corp Secretary of Prestige Consumer Healthcare, sold 8,987 shares of common stock at an average price of $81.85.

Prestige Consumer Healthcare's Chief Financial Officer, Christine Sacco, exercised stock options and sold shares on November 12, 2024.

An executive at Prestige Consumer Healthcare exercised stock options and sold shares on November 12, 2024.

Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare, executed stock options and sold shares on November 12, 2024.

Director Dawn M. Zier reports acquiring 2,202 shares of Prestige Consumer Healthcare Inc. stock as part of director compensation.

Sheila Hopkins, a director of Prestige Consumer Healthcare Inc., reports the acquisition of restricted stock units and disposal of common stock on August 6, 2024.

Director James D'Arecca acquired 2,202 shares of Prestige Consumer Healthcare Inc. common stock on August 6, 2024, as part of the director compensation program.

Director Celeste A. Clark reports acquisition of 2,202 restricted stock units of Prestige Consumer Healthcare Inc. as part of the director compensation program.